Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2010 Jan 20;2010(1):CD008285.
doi: 10.1002/14651858.CD008285.

Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis

Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration (CCCMAC)  1
Affiliations
Meta-Analysis

Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis

Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration (CCCMAC). Cochrane Database Syst Rev. .

Abstract

Background: After a 1999 National Cancer Institute (NCI) clinical alert was issued, chemoradiotherapy has become widely used in treating women with cervical cancer. Two subsequent systematic reviews found that interpretation of the benefits was complicated and some important clinical questions were unanswered.

Objectives: We initiated a meta-analysis seeking updated individual patient data (IPD) from all randomised controlled trials (RCTs) to assess the effect of chemoradiotherapy on all outcomes. We pre-specified analyses to investigate whether the effect of chemoradiotherapy differed by trial or patient characteristics.

Search strategy: We supplemented MEDLINE, LILACS and CANCERLIT searches with information from trial registers, by handsearching relevant meeting proceedings and by discussion with relevant trialists and organisations. Searches were updated until October 2009.

Selection criteria: Both published and unpublished trials were eligible for inclusion provided the patients had been randomised between radiotherapy (with or without surgery) versus concomitant chemoradiotherapy (with or without surgery); that the method of randomisation precluded prior knowledge of the treatment to be assigned; and that the trial had completed patient recruitment before the date of the final analyses.

Data collection and analysis: We carried out a quantitative meta-analysis using updated information from individual patients from all available RCTs. We sought data from all patients randomised in all eligible trials. We obtained updated information on survival, recurrence and date of last follow up. To avoid potential bias, we requested information for all randomised patients, including those who had been excluded from the investigators' original analyses.

Main results: Eighteen trials were identified and 15 of these were eligible for inclusion in the main analysis. On the basis of 13 trials that compared chemoradiotherapy versus the same radiotherapy, there was a 6% improvement in 5-year survival with chemoradiotherapy (hazard ratio (HR) = 0.81, P < 0.001). A larger survival benefit was seen for the two further trials in which chemotherapy was administered after chemoradiotherapy. There was a significant survival benefit for both the group of trials that used platinum-based (HR = 0.83, P = 0.017) and non-platinum based (HR = 0.77, P = 0.009) chemoradiotherapy, but no evidence of a difference in the size of the benefit by radiotherapy or chemotherapy dose or scheduling was seen. Chemoradiotherapy also reduced local and distant recurrence and progression and improved disease-free survival (DFS). There was a suggestion of a difference in the size of the survival benefit with tumour stage, but not across other patient subgroups. Acute haematological and gastro-intestinal toxicity were increased with chemoradiotherapy, but data were too sparse for an analysis of late toxicity.

Authors' conclusions: These results endorse the recommendations of the NCI alert, but also demonstrate their applicability to all women and a benefit of non-platinum based chemoradiotherapy. Furthermore, although these results suggest an additional benefit from adjuvant chemotherapy this requires testing in RCTs.

PubMed Disclaimer

Conflict of interest statement

There were no conflicts of interest declared.

Figures

1
1
Simple (unstratified ) Kaplan Meier Curves for Overall Survival: chemoradiotherapy versus radiotherapy and chemoradiotherapy plus chemotherapy versus radiotherapy CTRT ‐ chemoradiotherapy CT ‐ chemotherapy RT ‐ radiotherapy
2
2
Flow diagram showing deaths and recurrences (Chemoradiotherapy versus radiotherapy trials only)
3
3
Subgroup analysis for FIGO stage for chemoradiotherapy versus radiotherapy trials only (Overall survival and Disease‐free survival)
4
4
Simple (unstratified) Kaplan Meier Curves for Overall Survival: Chemoradiotherapy versus radiotherapy plus sensitivity analysis of other trial designs CTRT ‐ chemoradiotherapy; RT ‐ radiotherapy; HU ‐ hydroxyurea
1.1
1.1. Analysis
Comparison 1 Chemoradiotherapy ± chemotherapy versus radiotherapy, Outcome 1 Overall survival.
2.1
2.1. Analysis
Comparison 2 Chemoradiotherapy versus Radiotherapy, Outcome 1 Overall survival.
3.1
3.1. Analysis
Comparison 3 Chemoradiotherapy versus radiotherapy (plus sensitivity analysis of other trial designs), Outcome 1 Overall Survival.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Chen 1997a {published and unpublished data}
    1. Chen HW, Jei J, Wei L. A randomized trial of hyperthermo‐radiochemotherapy for uterine cancer. Chinese Journal of Oncology 1997;24:249‐51.
Chen 1997b {published and unpublished data}
    1. Chen HW, Jei J, Wei L. A randomized trial of hyperthermo‐radiochemotherapy for uterine cancer. Chinese Journal of Oncology 1997;24:249‐51.
Cikaric 2005 {published and unpublished data}
    1. Cikaric S, Petrovic‐Stupar S, Marjanov I, Rudan L, Colakovic S, Timasevic A, et al. Radiotherapy versus radiotherapy and chemotherapy of advanced cervical cancer: Regression of tumour, early and late sequalaes, relapses of disease and 3‐years survival (the third phase).. European Journal of Cancer 2005;3 (Suppl):266.
Garipağaoğlu 2004 {published and unpublished data}
    1. Garipağaoğlu M, Kayikcioglu F, Kose MF, Adli M, Gűlkesen KH, Koçak Z, et al. Adding concurrent low dose continuous infusion of cisplatin to radiotherapy in locally advanced cervical carcinoma: A prospective randomized pilot study. British Journal of Cancer 2004;77:581‐7. - PubMed
Kantardzic 2004 {published and unpublished data}
    1. Kantardzic N, Beslija S, Begic D. Comparison of parameters of myelotoxicity in patients treated with concomitant chemotherapy and radiotherapy versus radiotherapy alone. Medicinski Arhiv 2004;58:19‐22. - PubMed
Keys 1999 {published and unpublished data}
    1. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL, et al. Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. New England Journal of Medicine 1999;340:1154‐61. - PubMed
Lal 2004 {published and unpublished data}
    1. Saibish Kumar E, Lal P, Tiwari A, Kumar S, Dimri K, Rastogi N, et al. Chemo‐irradiation versus radiotherapy alone in locally advanced carcinoma of the uterine cervix: An onging phase III trial. Presented at the 23rd Annual Meeting of the European Society for Therapeutic Radiology and Oncology, Amsterdam, the Netherlands. October 24‐28. 2004; Vol. Abstract 673.
Lanciano 2005a {published and unpublished data}
    1. Lanciano RM, Calkins A, Bundy BN, Parham G, Lucci JA, Moore DH, et al. Randomized comparison of weekly cisplatin or protracted venous infusion of fluouracil in combination with pelvic radiation in advanced cervical cancer: A Gynecological Oncology Group study. Journal of Clinical Oncology 2005;23:8289‐95. - PubMed
Lanciano 2005b {published and unpublished data}
    1. Lanciano RM, Calkins A, Bundy BN, Parham G, Lucci JA, Moore DH, et al. Randomized comparison of weekly cisplatin or protracted venous infusion of fluouracil in combination with pelvic radiation in advanced cervical cancer: A Gynecological Oncology Group study. Journal of Clinical Oncology 2005;23:8289‐95. - PubMed
Leborgne 1995 {unpublished data only}
    1. Leborgne F. Unpublished.
Lorvidhaya 2003a {published and unpublished data}
    1. Lorvidhaya V, Chitapanaraux I, Sangruchi S, Lertsanguansinchai P, Kongthanarat Y, Tangkaratt S, et al. Concurrent mitomycin, 5‐fluourouracil and radiotherapy in the treatment of locally advanced carcinoma of the cervix: A randomized trial. International Journal of Radiation Oncology Biology and Physics 2003;55:1226‐32. - PubMed
Lorvidhaya 2003b {published and unpublished data}
    1. Lorvidhaya V, Chitapanaraux I, Sangruchi S, Lertsanguansinchai P, Kongthanarat Y, Tangkaratt S, et al. Concurrent mitomycin, 5‐fluourouracil and radiotherapy in the treatment of locally advanced carcinoma of the cervix: A randomized trial. International Journal of Radiation Oncology Biology and Physics 2003;55:1226‐32. - PubMed
Morris 1999 {published and unpublished data}
    1. Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para‐aortic irradiation for high‐risk cervical cancer: An update of Radiation Oncology Group Trial (RTOG) 90‐01. Journal of Clinical Oncology 2004;22:872‐80. - PubMed
    1. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenbach C, Stevens RE, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para‐aortic radiation for high‐risk cervical cancer. New England Journal of Medicine 1999;340:1137‐43. - PubMed
Onishi 2000 {published and unpublished data}
    1. Onishi H, Yagamushi M, Kuriyama K, Tsukamoto T, Ishigame K, Ichikawa T, et al. Effet of concurrent intra‐arterial infusion of platinum drugs for patients with stage III of IV uterine cervical cacner treated with radiotherapy. Cancer Journal of Scientific American 2000;6:40‐5. - PubMed
Pearcey 2002 {published and unpublished data}
    1. Pearcey R, Brundage M, Drouin P, Jeffrey J, Johnston D, Lukka H, et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. Journal of Clinical Oncology 2002;20:966‐72. - PubMed
Peters 2000 {published and unpublished data}
    1. Peters WA III, Lui PY, Barrett RJ, Stock RJ, Monk BJ, Berek JS, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high risk early stage cancer of the cervix. Journal of clinical oncology 2000;18:1606‐13. - PubMed
Pras 1995 {unpublished data only}
    1. Pras E. Unpublished.
Roberts 2000 {published and unpublished data}
    1. Roberts KB, Urdaneta N, Vera R, Vera A, Gutierrez E, Aguilar Y, et al. Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous cell carcinoma of the cervix. International Journal of Cancer 2000;90:206‐23. - PubMed
Rose 1999a {published and unpublished data}
    1. Rose PG, Bundy BN, Watkins EB, Thigpen T, Deppe G, Maiman MA, et al. Concurent cisplatin‐based radiotherapy and chemotherapy for locally advanced cervical cancer. New England Journal of Medicine 1999;340:1144‐53. - PubMed
Rose 1999b {published and unpublished data}
    1. Rose PG, Bundy BN, Watkins EB, Thigpen T, Deppe G, Maiman MA, et al. Concurent cisplatin‐based radiotherapy and chemotherapy for locally advanced cervical cancer. New England Journal of Medicine 1999;340:1144‐53. - PubMed
Thomas 1998a {published and unpublished data}
    1. Thomas G, Dembo A, Ackerman I, Franssen E, Balogh J, Fyles A, et al. A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5‐fluourouracil in locally advanced cervical cancer. Gynecologic Oncology 1998;69:137‐45. - PubMed
Thomas 1998b {published and unpublished data}
    1. Thomas G, Dembo A, Ackerman I, Franssen E, Balogh J, Fyles A, et al. A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5‐fluourouracil in locally advanced cervical cancer. Gynecologic Oncology 1998;69:137‐45. - PubMed
Whitney 1999 {published and unpublished data}
    1. Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea in stage IIB/IVA carcinoma of the cervix. Journal of Clinical Oncology 1999;17:1339‐48. - PubMed

References to studies excluded from this review

Bulnes 1986 {published data only}
    1. Bulnes R, Rivera R. Carcinoma of the uterine cervix: treatment with combined radiotherapy and chemotherapy [Carcinoma Epidermoide del cervix uterino: Tratamiento con radiotherapia y quimioterapia asociadas]. Prensa Medica Argentina 1986;73(3):100‐3.
Dawel 1997 {published data only}
    1. Dawel M, Brock A, Prager W, Pohlmann S, Schiller S. Simulatenous chemoradiotherapy with carboplatin in inoperable cervical cancer ‐ Results of a study [Simultane Radiochemotherapie mit Carboplatin beim inoperablen Zervixkarzinom ‐ Ergebinisse einer Studie]. Strahlentherapie Und Onkologie 1997;173(11):545.
Fernandez 1995 {published data only}
    1. Fernandez DJ, Vidyasagar MS, Rao KK, Shenoy A, Kasturi DP. Synchronous 5‐fluorouracil, mitomycin‐c and radiation therapy in the treatment of locally advanced carcimoma od the cervix. Proceedings of the 16th Annual Meeting of the Association of Radiation Oncologists of India 1995;Kerala:97‐103.
Hernandez 1991 {published data only}
    1. Hernandez JRA, Rafael de la Huerta S, Canfield FM, Orozco AF. Clinical stage III cervical cancer: treatment with combined chemotherapy and radiotherapy [Cáncer cervicouterino. Etapa clínica III. Tratamiento combinado de radioterapia quimioterapia.]. Ginecología y Obstetricia De Mexico 1991;59:238‐42. - PubMed
Lira‐Puerto 1989 {published data only}
    1. Lira‐Puerto R, Huerta R, Cortes H, Fernandez A, Silva A, Martinez R, et al. Cisplatin (CDDP) plus radiotherapy (RT) versus radiotherapy alone in locally advanced cervical cancer. Proceedings of the American Society of Clinical Oncology 1990;9:A633.
Singh 1985 {published data only}
    1. Singh P, Dharmalingham SK, Tan MK, Tan CK. Chemotherapy ‐ radiotherapy combination in the treatment of carcinoma of the cervix. Southeast Asian Journal of Tropical Medicine and Public Health 1985;16(4):665‐8. - PubMed
Singh 2003 {published data only}
    1. Singh TT, Singh IY, Sharma DT, Singh N. Role of chemoradiation in advanced cervical cancer. Indian Journal of Cancer 2003;40(3):101‐7. - PubMed
Tseng 1997 {published data only}
    1. Tseng C‐J, Chang C‐T, Lai C‐H, Soong Y‐K, Hong J‐H, Tang SG, et al. A randomized trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the cervix. Gynecologic Oncology 1997;66:52‐8. - PubMed
Wong 1989 {published data only}
    1. Wong LC, Choo YS, Choy D, Sham JST, Ma HK. Long‐term follow‐up of potentiation of radiotherapy by cis‐platinum in advanced cervical cancer. Gynecologic Oncology 1989;35:159‐63. - PubMed
Wong 1999 {published data only}
    1. Wong LC, Ngan ANY, Cheung ANY, Cheng DKL, Ng TY, Choy DTK. Chemoradiation and adjuvant chemotherapy in cervical cancer. Journal of Clinical Oncology 1999;17(7):2055‐60. - PubMed

Additional references

ABOC 1995
    1. Advanced Bladder Cancer Overview Collaboration. Does neo‐adjuvant cisplatin‐based chemotherapy improve the survival of patients with locally advanced bladder cancer: a meta‐analysis of individual patient data from randomised clinical trials. British Journal of Urology 1995;75:206‐13. - PubMed
Arbyn 2007
    1. Arbyn M, Raifu AO, Autier P, Ferlay J. Burden of cervical cancer in Europe: estimates for 2004. Annals of Oncology 2007;doi:10:1093/annonc/mdm079. - PubMed
Australian Institute of Health and Welfare 2007
    1. Australian Institute of Health and Welfare. Cervical Screening in Australia 2004‐2005. Cancer Series No. 38. Cat no. CAN 33.(Canberra: AIHW).
Canadian Cancer Society 2007
    1. Canadian Cancer Society / National Cancer Institute of Canada. Canadian Cancer Statistics 2007; Vol. Toronto, Canada.
DerSimonian 1986
    1. DerSimonian R, Laird N. Meta‐analysis in clinical trials. Controlled Clinical Trials 1986;7:177‐88. - PubMed
Dickersin 1995
    1. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. In: Chalmers I, Altman DG editor(s). Systematic Reviews. London: BMJ Publishing Group, 1995:17‐36. - PMC - PubMed
Green 2001
    1. Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta‐analysis. Lancet 2001;358:781‐6. - PubMed
Green 2005
    1. Green J, Kirwan J, Tierney J, Vale CL, Symonds PR, Fresco LL, et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database of Systematic Reviews 2005, Issue (Issue 3):CD002225.pub2. [DOI: 10.1002/14651858.CD002225.pub2] - DOI - PMC - PubMed
Higgins 2003
    1. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ 2003;327:557‐60. - PMC - PubMed
Kaplan 1958
    1. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. Journal of the American Statistical Association 1958;53:457‐81.
Lukka 2002
    1. Lukka H, Hirte H, Fyles A, Thomas G, Elit L, Johnston M, et al. Concurrent cisplatin‐based chemotherapy plus radiotherapy for cervical cancer ‐ a meta‐analysis. Clinical Oncology 2002;14:203‐12. - PubMed
Mitra 2006
    1. Mitra D, Ghosh B, Kar A, Basu S, Deb AR, Sur PK. Role of chemoradiotherapy in advanced carcinoma cervix. Journal of the Indian Medical Association 2006;104(8):432,434,436. - PubMed
National Cancer Institute 1999
    1. National Cancer Institute. NCI Issues Clinical Announcement on Cervical Cancer: Chemotherapy plus Radiation Improves Survival. [Web page] Available at http://www.nih.gov/news/pr/feb99/nci22.htm 1999.
Parkin 2002
    1. Parkin DM, Bray F, Ferlay J, Pisani Paola. Global cancer statistics, 2002. CA‐ Cancer J Clinicians 2005;55:74‐108. - PubMed
Parmar 1995
    1. Parmar MKB, Machin D. Survival Analysis: A Practical Approach. Chichester: John Wiley and Sons Ltd, 1995.
Parmar 1998
    1. Parmar MKB, Torri V, Stewart L. Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17:2815‐34. - PubMed
Pearcey 2007
    1. Pearcey R, Miao Q, Kong W, Zhang‐Salomens J, MacKillop WJ. Impact of adoption of Chemoradiotherapy on the outcome of cervical cancer in Ontario: Results of a population based cohort study. Journal of Clinical Oncology 2007;25(17):2383‐8. - PubMed
Ries 2006
    1. Ries LAG, Harkins D, Krapcho M, et al. SEER Cancer Statistics Review, 1975‐2003. National Cancer Institute, Bethseda, MD.Based on November 2005 SEER data submission,(posted to the SEER website, 2006).
Stewart 1995
    1. Stewart LA, Clarke MJ, on behalf of the Cochrane Working Party Group on Meta‐analysis using Individual Patient Data. Practical methodology of meta‐analyses (overviews) using updated individual patient data. Statistics in Medicine 1995;14:2057‐79. - PubMed
Symonds 2004a
    1. Symonds RP, Kirwan J, Williams CJ, Tierney JF, Green J, Collingwood M. Concomitant hydroxurea plus radiotherapy versus radiotherapy for carcinoma of the uterine cervix: a systematic review. Cochrane Database of Systematic Reviews 2004, Issue 1:CD003918. - PMC - PubMed
Symonds 2004b
    1. Symonds RP, Collingwood M, Kirwan J, Humber CE, Tierney JF, Green JA, et al. Concomitant hydroxyurea plus radiotherapy versus radiotherapy for carcinoma of the uterine cervix: a systematic review. Cancer Treatment Reviews 2004;30:405‐14. - PubMed
Tierney 2007
    1. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time‐to‐event data into meta‐analysis. Trials 2007;8(1):16. - PMC - PubMed
Trimble 2007
    1. Trimble E, Gius D, Harlan LC. Impact of NCI announcement upon use of chemoradiation for women with cervical cancer. Journal of Clinical Oncology 2007;25(18S):5537.
Yusuf 1985
    1. Yusuf S, Peto R, Lewis JA, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Progress in Cardiovascular Diseases 1985;27:335‐71. - PubMed

References to other published versions of this review

CCCMAC 2008
    1. Chemoradiotherapy for cervical cancer meta‐analysis collaboration. Reducing Uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta‐analysis of individual patient data from 18 randomised trials. Journal of Clinical Oncology 2008;26:5802‐12. - PMC - PubMed

MeSH terms